Vaccinations in patients with multiple sclerosis: review and recommendations

Cassie Nesbitt^{1

2}, Louise Rath¹, Michael Zhong^{1

2}, Allen C Cheng^{1

2}, Helmut Butzkueven^{1

2}, Robb Wesselingh^{1

2}, Olga Skibina¹, Mastura Monif^{1

2}, Wei Yeh^{1

2}, Julia Ml Brotherton^{3

4}, Stephen Reddel⁵, Anneke Van Der Walt^{1

2}

Affiliations

Review

Cassie Nesbitt et al. Med J Aust. 2021 May.

. 2021 May;214(8):350-354.e1.

doi: 10.5694/mja2.51012. Epub 2021 Apr 18.

No abstract available

Keywords: Central nervous system infections; Demyelinating diseases; Multiple sclerosis; Vaccination.

References

1. Buljevac D, Flach HZ, Hop WCJ, et al. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 2002; 125: 952-960.
1. Bua A, Ruggeri M, Zanetti S, et al. Effect of teriflunomide on QuantiFERON-TB Gold results. Med Microbiol Immunol 2017; 206: 73-75.
1. Loebermann M, Winkelmann A, Hartung H-P, et al. Vaccination against infection in patients with multiple sclerosis. Nat Rev Neurol 2012; 8: 143-151.
1. Olberg HK, Eide GE, Cox RJ, et al. Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy. Eur J Neurol 2018; 25: 527-534.
1. Australian Technical Advisory Group on Immunisation. Australian immunisation handbook. Canberra: Australian Government Department of Health, 2018. https://immunisationhandbook.health.gov.au (viewed Sept 2020).